EDGAR Filing Documents for 0001501989-15-000002

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001501989-15-000002

Filing Date

2015-06-25

Accepted

2015-06-25 12:14:56

Documents

Effectiveness Date

2015-06-25

Items

Item 06b:

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	9822
	Complete submission text file	0001501989-15-000002.txt		10902

Mailing Address 650 GATEWAY BLVD. SUITE 125 SOUTH SAN FRANCISCO CA 94080

Business Address 650 GATEWAY BLVD. SUITE 125 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)